John M. Leonard
2021 - Intellia Therapeutics
In 2021, John M. Leonard earned a total compensation of $9.8M as President, Chief Executive Officer at Intellia Therapeutics, a 169% increase compared to previous year.
Compensation breakdown
Bonus | $462,000 |
---|---|
Option Awards | $6,876,888 |
Salary | $600,000 |
Stock Awards | $1,811,748 |
Other | $22,924 |
Total | $9,773,560 |
Leonard received $6.9M in option awards, accounting for 70% of the total pay in 2021.
Leonard also received $462K in bonus, $600K in salary, $1.8M in stock awards and $22.9K in other compensation.
Rankings
In 2021, John M. Leonard's compensation ranked 1,079th out of 12,415 executives tracked by ExecPay. In other words, Leonard earned more than 91.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,079 out of 12,415 | 91st |
Division Manufacturing | 370 out of 5,508 | 93rd |
Major group Chemicals And Allied Products | 131 out of 2,378 | 95th |
Industry group Drugs | 110 out of 2,099 | 95th |
Industry In Vitro and In Vivo Diagnostic Substances | 2 out of 61 | 97th |
Source: SEC filing on May 2, 2022.
Leonard's colleagues
We found four more compensation records of executives who worked with John M. Leonard at Intellia Therapeutics in 2021.